Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-048491

Options or other derivatives

  • VP, Finance acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Groenewald Ferdinand VP, Finance 2025-03-29 Grant or award · Employee Stock Option (right to buy) +3,000 3,000 D
Loading xslF345X05/ownership.xml…